S M Lippman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S M Lippman

Showing results (201-210 of 240) with videos related to

Pageof 24

Sort By:

Cancer|April 3, 2001

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.

The New England Journal of Medicine|September 20, 1990

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neckW K Hong, S M Lippman, L M Itri, et al.

Gynecologic Oncology|January 15, 1999

13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trialG R Weiss, P Y Liu, D S Alberts, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neckB Brockstein, D J Haraf, K Stenson, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000

Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamideE Singletary, R Lieberman, N Atkinson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996

Increased epidermal growth factor receptor expression in metaplastic bronchial epitheliumJ M Kurie, H J Shin, J S Lee, et al.

Archives of Otolaryngology--Head & Neck Surgery|October 16, 1999

Biochemoprevention for dysplastic lesions of the upper aerodigestive tractV A Papadimitrakopoulou, G L Clayman, D M Shin, et al.

Cancer|September 1, 1991

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.

Oncogene|May 10, 2006

15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gammaV Subbarayan, P Krieg, L C Hsi, et al.

Journal of the National Cancer Institute|July 1, 1992

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.

Pageof 24

Search research articles

Showing results (201-210 of 240) with videos related to

Sort By:

Pageof 24

Cancer|April 3, 2001

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.

The New England Journal of Medicine|September 20, 1990

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neckW K Hong, S M Lippman, L M Itri, et al.

Gynecologic Oncology|January 15, 1999

13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trialG R Weiss, P Y Liu, D S Alberts, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000

Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamideE Singletary, R Lieberman, N Atkinson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996

Increased epidermal growth factor receptor expression in metaplastic bronchial epitheliumJ M Kurie, H J Shin, J S Lee, et al.

Archives of Otolaryngology--Head & Neck Surgery|October 16, 1999

Biochemoprevention for dysplastic lesions of the upper aerodigestive tractV A Papadimitrakopoulou, G L Clayman, D M Shin, et al.

Cancer|September 1, 1991

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.

Oncogene|May 10, 2006

Journal of the National Cancer Institute|July 1, 1992

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancerJ S Lee, H I Libshitz, F V Fossella, et al.

Pageof 24